U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

4-FLUOROAMPHETAMINE

MORE DETAILS

S5744XYR1Z

Status:
Possibly Marketed Outside US
Source:
NCT00295191: Phase 4 Interventional Completed End-stage Renal Disease
(2005)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT00295191
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Dopamine transporter
183
Norepinephrine transporter
197
Serotonin transporter
183

4-FLUOROAMPHETAMINE HYDROCHLORIDE

MORE DETAILS

YIJ78M8D5Q

Status:
Possibly Marketed Outside US
Source:
NCT00295191: Phase 4 Interventional Completed End-stage Renal Disease
(2005)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT00295191
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Dopamine transporter
183
Norepinephrine transporter
197
Serotonin transporter
183
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966